Table 3.

Discrimination of screening instruments for mortality of older hospitalized COVID-19 patients

Variable	In-hospital mortality			30-Days-mortality
	AUC	Sensitivity	Specificity	AUC	Sensitivity	Specificity
APOP high riska	0.56 (0.48–0.63)	44 (33–55)	67 (61–72)	0.62 (0.55–0.68)	52 (42–61)	71 (66–77)
High CFSb	0.58 (0.51–0.65)	66 (54–77)	50 (44–56)	0.62 (0.56–0.69)	71 (61–80)	53 (47–60)
High agec	0.54 (0.46–0.61)	52 (41–63)	55 (50–61)	0.59 (0.53–0.65)	59 (49–68)	59 (53–65)

Analysis sensitivity/specificity Clopper-Pearson CI. All values between brackets are 95% confidential intervals. All numbers > 1 are percentages

^a45% and more risk for mortality or functional decline on APOP screener

^bCFS ≥ 4

^c > 80 years